Back
Immunome, Inc. Stock Predictions
Know when to buy, sell, or hold. Rate Any Stock In Seconds
Get Your Free Stock Analysis Now
Buy
60
IMNM
Immunome, Inc.
Last Price:
$25.11
Seasonality Move:
7.25%
7 Day Trial
ALL ACCESS PASS
$
7
Color-coded buy, sell, hold signals make stock decisions simple.
Get Your Free Stock Analysis NowImmunome, Inc. Stock Forecast
-
Over the next 52 weeks, Immunome, Inc. has on average historically risen by 48.4% based on the past 5 years of stock performance.
-
Immunome, Inc. has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
-
Is Immunome, Inc. Stock Undervalued?The current Immunome, Inc. [IMNM] share price is $24.75. The Score for IMNM is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
IMNM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Immunome, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Immunome, Inc. has on average historically risen by 48.4% based on the past 5 years of stock performance.
Immunome, Inc. Stock Rating
Buy
60
Immunome, Inc. (IMNM)
is a Buy
Is Immunome, Inc. overpriced?
-
Immunome, Inc. has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
Immunome, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
immunome.com
52-Week Data
52-Week High:
26.63
52-Week Low:
5.15
Prediction Charts
Market Cap:
2.3B
Price in USD:
24.75
Volume:
1.2M
Beta:
1.94
Technical Analysis
SMA50:
20.67
SMA100:
16.97
SMA200:
13.05
52-Wk Change:
167.86%
Stock Predictions
-
Is Immunome, Inc. stock public?Yes, Immunome, Inc. is a publicly traded company.
-
What is the Immunome, Inc. stock quote today?The Immunome, Inc. stock price is 24.75 USD today.
-
How to buy Immunome, Inc. stock online?You can buy Immunome, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-8 | 19.55 | 20.45 | 20.80 | 19.42 |
| Jan-9 | 20.92 | 21.07 | 22.01 | 20.73 |
| Jan-12 | 20.97 | 20.57 | 21.21 | 19.60 |
| Jan-13 | 20.42 | 20.14 | 20.44 | 19.67 |
| Jan-14 | 20.16 | 20.76 | 21.16 | 20.06 |
| Jan-15 | 20.61 | 22.85 | 22.91 | 20.05 |
| Jan-16 | 22.86 | 22.41 | 23.35 | 22.24 |
| Jan-20 | 21.56 | 23.88 | 24.02 | 21.39 |
| Jan-21 | 23.89 | 24.87 | 24.92 | 23.51 |
| Jan-22 | 24.84 | 25.82 | 25.85 | 24.50 |
| Jan-23 | 25.63 | 25.87 | 26.36 | 24.85 |
| Jan-26 | 25.53 | 25.43 | 26.63 | 24.82 |
| Jan-27 | 25.45 | 25.70 | 25.97 | 24.91 |
| Jan-28 | 25.66 | 24.75 | 25.90 | 24.65 |
Immunome, Inc. Earnings
Immunome, Inc. Earnings Report: Per Share Immunome, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Immunome, Inc. Forecast Revenue Growth
Immunome, Inc. Stock Analysis: Historical quarterly revenues per share for Immunome, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.26 per share, and an increase next year of $0.36 per share.
* Immunome, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.